AAIC 2025 Abstract
Diagnostic performance of MK and Flortaucipir tau PET for the biological staging of Alzheimer disease
By Marina Scop Madeiros, Pâmela C.L. Ferreira, Bruna Bellaver, Show 23 more authorsTharick Ali Pascoal
Study in peopleBiomarkers
Abstract
Background: The Alzheimer's Association workgroup criteria (AA‐2024) suggest four biological stages based on PET imaging. However, the application of this framework may vary depending on the tau PET tracer used, and the distribution of clinical stages by biological stage may differ.
